Skip to content

Montmorency Cherry Juice and Uric Acid Metabolism

The Influence of Tart Montmorency Cherries on Indices of Uric Acid Metabolism

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01825070
Enrollment
12
Registered
2013-04-05
Start date
2012-03-31
Completion date
2013-03-31
Last updated
2013-04-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Inflammation

Keywords

Montmorency tart cherries, Inflammation, Uric acid

Brief summary

Cherries have been show to possess the ability to reduce uric acid concentrations and inflammation. Tart Montmorency cherries possess a higher concentration of the plant compounds than other cherries and hence makes the expectation possible that Montmorency cherries will lower uric acid and inflammation.

Detailed description

Plasma and urinary uric acid concentration, plasma phytochemical content and inflammatory biomarkers will be measured in order to elucidate the effects of an acute dose of tart cherry juice on indices related to the condition of gout. Participants will be required to attend the laboratory at a range of time points over two periods of 96 hours, separated by a 7 day washout period, to provide blood samples. In order to provide a baseline sample, participants will attend the laboratory in the morning following an overnight fast and voiding of any urine. Following this participants will be given 30mls (30 mls provides 323 mg/380 µmol of anthocyanins) of tart cherry juice or placebo, diluted with 60 mls of water to consume within 10 minutes. Participants will be required to consume identical dosages of the supplement immediately prior to evening meals and breakfasts (or same time each morning following blood sampling if non-breakfast eater) over the next 96 hours. Further blood and urine samples will be collected at 1, 2, 3, 5, 8, 24, 26, 48, 50, 72, 74 and 96 hours and will require participants to return to the laboratory at each of these time points. Following the first period of supplementation participants will complete a 7 day washout period in which they will not be required to attend the laboratory. Following the washout period they will repeat the supplementation period consuming the supplement they did not receive during the first period.

Interventions

DIETARY_SUPPLEMENTMontmorency cherry concentrate

Tart Montmorency cherry juice concentrate

Sponsors

Northumbria University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
SINGLE_GROUP
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* apparently healthy males/females between the ages of 18-40 years

Exclusion criteria

* underlying clinical pathology

Design outcomes

Primary

MeasureTime frameDescription
Change in uric acid0, 1, 2, 3, 5, 8, 24, 26, 48 hoursmeasurement of changes in uric acid over a 48h period

Secondary

MeasureTime frameDescription
Change in C-reactive protein0,1,2,3,5,8,24,26,48 hoursmeasurement of changes in c-reative protein over a 48h period

Other

MeasureTime frameDescription
Change in anthocyanins, polyphenolics and creatinine0,1,2,3,5,8,24,26,48 hoursmeasurement of changes in anthocyanins, polyphenolics and creatinine over a 48h period

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 23, 2026